mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |